Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

Aims/Introduction:  Patients with type 2 diabetes mellitus often require treatment with more than one oral antihyperglycemic agent to achieve their glycemic goal. The present study was carried out to assess the efficacy and safety of sitagliptin as add‐on therapy in Japanese patients with type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Atsunori, Kadowaki, Takashi, Tajima, Naoko, Nonaka, Kenji, Taniguchi, Tadaaki, Nishii, Mikio, Ferreira, Juan Camilo Arjona, Amatruda, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019307/
https://www.ncbi.nlm.nih.gov/pubmed/24843518
http://dx.doi.org/10.1111/j.2040-1124.2011.00120.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019307/
https://www.ncbi.nlm.nih.gov/pubmed/24843518
http://dx.doi.org/10.1111/j.2040-1124.2011.00120.x

Ejemplares similares